Biochemical restoration of aged human Bruch's membrane: Experimental studies to improve retinal pigment epithelium transplant survival and differentiation

Developments in Ophthalmology

Volumn 53, Issue , 2014, Pages 133-142

  Sugino, Ilene K ^a   Sun, Qian ^a   Cheewatrakoolpong, Noounanong ^a   Malcuit, Christopher ^b   Zarbin, Marco A ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b KENT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRUCH MEMBRANE; CELL CULTURE; CELL SURVIVAL; HUMAN; MACULAR DEGENERATION; PATHOLOGY; PHYSIOLOGY; PIGMENT EPITHELIUM; TRANSPLANTATION;

ANIMALS; BRUCH MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM;

EID: 84922270394     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000358531     Document Type: Article

References (59)

1. Zarbin MA, Rosenfeld PJ: Pathwaybased therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina 2010; 30: 1350-1367.
2. Kubota R, Boman NL, David R, Mallikaarjun S, Patil S, Birch D: Safety and effect on rod function of acu-4429, a novel small-molecule visual cycle modulator. Retina 2012; 32: 183-188.
3. Mata NL, Lichter JB, Vogel R, Han Y, Bui TV, Singerman LJ: Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina 2013; 33: 498-507.
4. Zhang K, Hopkins JJ, Heier JS, et al: Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA 2011; 108: 6241-6245.
5. Schwartz SD, Hubschman JP, Heilwell G, et al: Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379: 713-720.
6. Binder S, Stanzel BV, Krebs I, Glittenberg C: Transplantation of the RPE in AMD. Prog Retin Eye Res 2007; 26: 516-554.
7. Falkner-Radler CI, Krebs I, Glittenberg C, et al: Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol 2011; 95: 370-375.
8. Zarbin MA: Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane. Trans Am Ophthalmol Soc 2003; 101: 499-520.
9. Ishida M, Lui GM, Yamani A, Sugino IK, Zarbin MA: Culture of human retinal pigment epithelial cells from peripheral scleral flap biopsies. Curr Eye Res 1998; 17: 392-402.
10. Tsukahara I, Ninomiya S, Castellarin A, Yagi F, Sugino IK, Zarbin MA: Early attachment of uncultured retinal pigment epithelium from aged donors onto Bruch's membrane explants. Exp Eye Res 2002; 74: 255-266.
11. Wang H, Van Patten Y, Sugino IK, Zarbin MA: Migration and proliferation of retinal pigment epithelium on extracellular matrix ligands. J Rehabil Res Dev 2006; 43: 713-722.
12. Hageman GS, Anderson DH, Johnson LV, et al: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
13. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
14. Klein RJ, Zeiss C, Chew EY, et al: Complement factor H polymorphism in agerelated macular degeneration. Science 2005; 308: 385-389.
15. Boulton M, Roanowska M, Wess T: Ageing of the retinal pigment epithelium: implications for transplantation. Graefes Arch Clin Exp Ophthalmol 2004; 242: 76-84.
16. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA: Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res 2005; 80: 235-248.
17. Gullapalli VK, Kodair M, Wang H, Sugino IK, Madreperla S, Zarbin MA: Transplantation frontiers; in Ryan SJ (ed): Retina. Amsterdam, Elsevier, 2013, pp 2058-2077.
18. Gullapalli VK, Sugino IK, Zarbin MA: Muller cells and the retinal pigment epithelium; in Albert D, Miller J, Azar D, Blodi B (eds): Albert and Jakobiec's Principles and Practice of Ophthalmology, ed 3. Philadelphia, Saunders, 2008, pp 1633-1655.
19. Zarbin M: The promise of stem cells for age-related macular degeneration and other retinal degenerative diseases. Drug Discov Today Ther Strateg 2012, E-pub ahead of print.
20. Klimanskaya I, Rosenthal N, Lanza R: Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev 2008; 7: 131-142.
21. Carr AJ, Vugler AA, Hikita ST, et al: Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009; 4:e8152.
22. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R: Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004; 6: 217-245.
23. Vollrath D, Feng W, Duncan JL, et al: Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci USA 2001; 98: 12584-12589.
24. Lu B, Malcuit C, Wang S, et al: Longterm safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27: 2126-2135.
25. Carr AJ, Vugler A, Lawrence J, et al: Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 2009; 15: 283-295.
26. Lund RD, Wang S, Klimanskaya I, et al: Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006; 8: 189-199.
27. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R: Human embryonic stem cell lines derived from single blastomeres. Nature 2006; 444: 481-485.
28. Sugino IK, Sun Q, Wang J, et al: Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest Ophthalmol Vis Sci 2011; 52: 4979-4997.
29. Sugino IK, Rapista A, Sun Q, et al: A method to enhance cell survival on Bruch's membrane in eyes affected by age and age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52: 9598-9609.
30. Sugino IK, Gullapalli VK, Sun Q, et al: Cell-deposited matrix improves retinal pigment epithelium survival on aged submacular human Bruch's membrane. Invest Ophthalmol Vis Sci 2011; 52: 1345-1358.
31. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P: RPE transplantation and its role in retinal disease. Prog Retin Eye Res 2007; 26: 598-635.
32. Coffey PJ, Girman S, Wang SM, et al: Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci 2002; 5: 53-56.
33. Girman SV, Wang S, Lund RD: Cortical visual functions can be preserved by subretinal RPE cell grafting in RCS rats. Vision Res 2003; 43: 1817-1827.
34. Gias C, Jones M, Keegan D, et al: Preservation of visual cortical function following retinal pigment epithelium transplantation in the RCS rat using optical imaging techniques. Eur J Neurosci 2007; 25: 1940-1948.
35. Wang S, Lu B, Girman S, Holmes T, Bischoff N, Lund RD: Morphological and functional rescue in RCS rats after RPE cell line transplantation at a later stage of degeneration. Invest Ophthalmol Vis Sci 2008; 49: 416-421.
36. Zarbin MA: Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598-614.
37. Marshall J, Hussain AA, Starita C, Moore DJ, Patmore AL: Aging and Bruch's membrane; in Marmor MF, Wolfensberger TJ (eds): The Retinal Pigment Epithelium. New York, Oxford University Press, 1998, pp 669-692.
38. Abdelsalam A, Del Priore L, Zarbin MA: Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999; 44: 1-29.
39. Guymer R, Luthert P, Bird A: Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res 1999; 18: 59-90.
40. Pauleikhoff D, Wojteki S, Muller D, Bornfeld N, Heiligenhaus A: Adhesive properties of basal membranes of Bruch's membrane. Immunohistochemical studies of age-dependent changes in adhesive molecules and lipid deposits (in German). Ophthalmologe 2000; 97: 243-250.
41. Anderson SS, Kim Y, Tsilibary EC: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 1994; 46: 1359-1367.
42. Krishnamurti U, Rondeau E, Sraer JD, Michael AF, Tsilibary EC: Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 1997; 272: 27966-27970.
43. Paul RG, Bailey AJ: The effect of advanced glycation end-product formation upon cell-matrix interactions. Int J Biochem Cell Biol 1999; 31: 653-660.
44. Del Priore LV, Geng L, Tezel TH, Kaplan HJ: Extracellular matrix ligands promote RPE attachment to inner Bruch's membrane. Curr Eye Res 2002; 25: 79-89.
45. Tezel TH, Del Priore LV, Kaplan HJ: Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci 2004; 45: 3337-3348.
46. Song MK, Lui GM: Propagation of fetal human RPE cells: preservation of original culture morphology after serial passage. J Cell Physiol 1990; 143: 196-203.
47. Tseng SC, Savion N, Gospodarowicz D, Stern R: Characterization of collagens synthesized by cultured bovine corneal endothelial cells. J Biol Chem 1981; 256: 3361-3365.
48. Robinson J, Gospodarowicz D: Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells. J Cell Physiol 1983; 117: 368-376.
49. Katz A, Fish AJ, Pe'er J, Frucht-Pery J, Ron N, Vlodavsky I: Entactin/nidogen: synthesis by bovine corneal endothelial cells and distribution in the human cornea. Invest Ophthalmol Vis Sci 1994; 35: 495-502.
50. Menashi S, Vlodavsky I, Ishai-Michaeli R, Legrand Y, Fridman R: The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A. FEBS Lett 1995; 361: 61-64.
51. Gospodarowicz DJ: Extracellular matrices and the control of cell proliferation and differentiation in vitro. Prog Clin Biol Res 1984; 145: 103-128.
52. Binder S: Scaffolds for retinal pigment epithelium (RPE) replacement therapy. Br J Ophthalmol 2011; 95: 441-442.
53. Hu Y, Liu L, Lu B, et al: A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res 2012; 48: 186-191.
54. Hynes SR, Lavik EB: A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol 2010; 248: 763-778.
55. Krishna Y, Sheridan C, Kent D, Kearns V, Grierson I, Williams R: Expanded polytetrafluoroethylene as a substrate for retinal pigment epithelial cell growth and transplantation in age-related macular degeneration. Br J Ophthalmol 2011; 95: 569-573.
56. Wang S, Lu B, Wood P, Lund RD: Grafting of ARPE-19 and Schwann cells to the subretinal space in RCS rats. Invest Ophthalmol Vis Sci 2005; 46: 2552-2560.
57. Lund RD, Wang S, Lu B, et al: Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007; 25: 602-611.
58. Lawrence JM, Sauve Y, Keegan DJ, et al: Schwann cell grafting into the retina of the dystrophic RCS rat limits functional deterioration. Invest Ophthalmol Vis Sci 2000; 41: 518-528.
59. Lawrence JM, Keegan DJ, Muir EM, et al: Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 2004; 45: 267-274.